BNTC (Benitec Biopharma Inc. Common Stock)
Insider Trading Activity
Every open-market purchase and sale reported by BNTC officers, directors and 10%+ beneficial owners on SEC Form 4, which must be filed within two business days of the transaction. Sales often reflect scheduled 10b5-1 plans or tax withholding rather than a directional view, so read counts alongside the size and the filer.
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.
| Filed | Insider | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-05-28 | David Matthew Friedman | Director | A | — | — |
| 2026-01-26 | Sharon Mates | Director | A | — | — |
| 2025-12-29 | Aaron Cowen | 10%+ Owner | Buy | — | — |
| 2025-12-22 | Averill Madison Master Fund, Ltd. | Director | Buy | — | — |
| 2025-12-03 | Edward F Smith | Director | A | — | — |
| 2025-12-03 | Peter Francis | Director | A | — | — |
| 2025-12-03 | J KEVIN BUCHI | Director | A | — | — |
| 2025-12-03 | Kishan Mehta | Director | A | — | — |
| 2025-12-03 | Sharon Mates | Director | A | — | — |
| 2025-11-20 | Sophie Mukadam | Chief Operating Officer | A | — | — |
| 2025-11-20 | Megan Boston | Chief Financial Officer | A | — | — |
| 2025-11-20 | Jerel A. Banks | Chief Executive Officer | A | — | — |
| 2025-11-10 | Averill Madison Master Fund, Ltd. | Director | Buy | — | — |
| 2025-11-07 | Sharon Mates | Director | A | — | — |
| 2025-04-02 | Averill Madison Master Fund, Ltd. | Director | Buy | — | — |
| 2025-03-28 | SUVRETTA CAPITAL MANAGEMENT, LLC | Director | Buy | — | — |
| 2025-03-13 | J KEVIN BUCHI | Director | G | — | — |
| 2025-03-03 | J KEVIN BUCHI | Director | M | — | — |
| 2024-12-26 | SUVRETTA CAPITAL MANAGEMENT, LLC | Director | Buy | — | — |
| 2024-12-11 | Edward F Smith | Director | A | — | — |
| 2024-12-11 | Megan Boston | Executive Director | A | — | — |
| 2024-12-11 | J KEVIN BUCHI | Director | A | — | — |
| 2024-12-11 | Peter Francis | Director | A | — | — |
| 2024-12-11 | Jerel A. Banks | Chief Executive Officer | A | — | — |
| 2024-12-11 | Kishan Mehta | Director | A | — | — |
| 2024-12-05 | Aaron Cowen | 10%+ Owner | Buy | — | — |
| 2024-11-21 | SUVRETTA CAPITAL MANAGEMENT, LLC | Director | Buy | — | — |
| 2024-09-30 | SUVRETTA CAPITAL MANAGEMENT, LLC | Director | X | — | — |
| 2024-03-08 | Jerel A. Banks | Chief Executive Officer | A | — | — |
| 2024-03-08 | Megan Boston | Executive Director | A | — | — |
| 2023-12-07 | Edward F Smith | Director | A | — | — |
| 2023-12-07 | J KEVIN BUCHI | Director | A | — | — |
| 2023-12-07 | Peter Francis | Director | A | — | — |
| 2023-08-14 | J KEVIN BUCHI | Director | Buy | — | — |
| 2023-08-14 | Megan Boston | Executive Director | Buy | — | — |
| 2023-06-15 | Jerel A. Banks | Chief Executive Officer | A | — | — |
| 2023-06-15 | Megan Boston | Executive Director | A | — | — |
| 2022-12-09 | Peter Francis | Director | A | — | — |
| 2022-12-09 | Edward F Smith | Director | A | — | — |
| 2022-12-09 | J KEVIN BUCHI | Director | A | — | — |
| 2021-12-10 | Peter Francis | Director | A | — | — |
| 2021-12-10 | Edward F Smith | Director | A | — | — |
| 2021-12-10 | J KEVIN BUCHI | Director | A | — | — |
| 2021-12-09 | Steven Michael Oliveira | 10%+ Owner | Buy | — | — |
| 2020-12-11 | Megan Boston | Executive Director | A | — | — |
| 2020-12-11 | J KEVIN BUCHI | Director | A | — | — |
| 2020-12-11 | Peter Francis | Director | A | — | — |
| 2020-12-11 | Jerel A. Banks | Chief Executive Officer | A | — | — |
| 2020-12-11 | Edward F Smith | Director | A | — | — |
| Insider | Role | Shares Held | Value |
|---|---|---|---|
| — | Director | 9,546,875 | — |
| — | Director | 8,793,245 | — |
| — | 10%+ Owner | 1,836,569 | — |
| — | Director | 103,910 | — |
| — | 10%+ Owner | 55,971 | — |
| — | Chief Financial Officer | 25,927 | — |
Form 4 reports a change in beneficial ownership by an officer, director or 10%+ holder, and must be filed within two business days of the transaction — so this is close to real time, unlike the 45-day-lagged 13F institutional data.
Transaction codes matter more than the raw buy/sell count. Code P is an open-market purchase — an insider choosing to buy with their own money, which is the signal most research treats as informative. Code S is a sale, but sales are frequently pre-scheduled under a 10b5-1 plan or cover tax withholding on vesting equity, so a run of sales often says nothing directional. Codes A and M are grants and option exercises rather than open-market decisions.
Full filing history and per-insider positions are on the BNTC quote page; the site-wide leaderboard is on the insider transactions hub.